RetaMaps

ShiftSetGo Bellingham

ShiftSetGo Bellingham · 1301 West Bakerview Road · Bellingham, WA 98226

4.9· 16 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

Care described on the practice's website

  • GLP-1 medications named on site
  • Medically supervised weight loss

About this practice

In Bellingham, Washington, ShiftSetGo offers coached weight loss as described on its website: weekly one-on-one coaching, meal replacements, and a Shift Plus option that adds tirzepatide injections, with cryo body sculpting and red light therapy also listed. The site dates the company to 2003 and mentions a board-certified holistic health coach. Because the main service is coaching, ask who prescribes the injections and how visits are supervised. This location has a 4.9-star Google rating across 16 reviews dating back to 2017, with none in the past year, and 8 reviews mention results.

Services & access

Advertises semaglutide todayNot listed
Advertises tirzepatide todayYes
Telehealth visitsNot listed
Cash pay accepted—
Accepts insurance — per practice websiteYes
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 4.9
Google rating · 16 reviews
6
reviews mention weight loss

Counts computed by RetaMaps from public Google reviews; most recent review 2025-05-21. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★4.9 across 16 Google reviews. Of the 16 reviews we analyzed, 16 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).

What patients like

  • Weight-loss results8 reviews

Common complaints

No negative reviews among those we analyzed.

5★
15
4★
1
3★
0
2★
0
1★
0

Most recent Google reviews

Stacy E.★★★★★2025-05-21

I have been doing Red Light Therapy and have noticed an amazing improvement. Sleeping better, weight loss, less pain. Waiting to see what continues to happen ☺️

Sulene K.★★★★★2022-11-28

Mardi & Cheryl are awesome coaches! They care, encourage and have knowledge to help keep me moving forward in my health goals! I highly recommend, not only this location, but this program!

Stacee A.★★★★★2022-06-08

I love this program because IT WORKS! I have lost 45 lbs in 4 months. What is great is I don't feel hungry they have delicious bars that are favorite to eat on the go and help if you are craving something sweet!

Sara B.★★★★★2022-03-26

This company knows how to help clients focus on healthy eating - for life! It's not a fad weight loss company. Their coaches teach you a nutritional way of eating that is actually good for you and will sustain your weight loss for years, as long as you stick with what you learn while in it. 😉 Food products are delicious and it's a really simple program to follow.

Deep V.★★★★★2021-07-19

I appreciate coaches getting back to me quickly.

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Nearby providers in Bellingham

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs